Yilan Shen

603 total citations
20 papers, 453 citations indexed

About

Yilan Shen is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Yilan Shen has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Immunology. Recurrent topics in Yilan Shen's work include Chronic Kidney Disease and Diabetes (5 papers), Inflammasome and immune disorders (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yilan Shen is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Inflammasome and immune disorders (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yilan Shen collaborates with scholars based in China, Macao and United States. Yilan Shen's co-authors include Wei Chen, Jiajun Fan, Xiaobin Mei, Dianwen Ju, Qi Bian, Jingyun Luan, Xuyao Zhang, Tao Ding, Wenjing Zai and Shaofei Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Microbiology and Biotechnology and Journal of Ethnopharmacology.

In The Last Decade

Yilan Shen

18 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yilan Shen China 10 212 99 60 52 51 20 453
Zi-Yue Wan China 10 248 1.2× 153 1.5× 56 0.9× 35 0.7× 47 0.9× 17 457
Zeyuan Lin China 12 258 1.2× 78 0.8× 64 1.1× 32 0.6× 40 0.8× 15 438
Haiming Xiao China 12 270 1.3× 68 0.7× 62 1.0× 36 0.7× 43 0.8× 23 473
Zhimin Mao China 14 179 0.8× 78 0.8× 37 0.6× 33 0.6× 36 0.7× 30 443
Yuebo Huang China 12 315 1.5× 123 1.2× 60 1.0× 29 0.6× 87 1.7× 14 587
Bu-Hui Liu China 9 198 0.9× 108 1.1× 50 0.8× 28 0.5× 40 0.8× 21 378
Yongli Zhan China 13 185 0.9× 203 2.1× 97 1.6× 33 0.6× 50 1.0× 33 636
Yuan-ye Qiu China 10 257 1.2× 97 1.0× 115 1.9× 62 1.2× 46 0.9× 13 535
Pengxun Han China 11 202 1.0× 84 0.8× 71 1.2× 44 0.8× 15 0.3× 22 392
Anmei Shu China 9 211 1.0× 67 0.7× 35 0.6× 20 0.4× 44 0.9× 13 402

Countries citing papers authored by Yilan Shen

Since Specialization
Citations

This map shows the geographic impact of Yilan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilan Shen more than expected).

Fields of papers citing papers by Yilan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilan Shen. The network helps show where Yilan Shen may publish in the future.

Co-authorship network of co-authors of Yilan Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yilan Shen. A scholar is included among the top collaborators of Yilan Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilan Shen. Yilan Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Yilan, et al.. (2025). LiDAR, IMU, and camera fusion for simultaneous localization and mapping: a systematic review. Artificial Intelligence Review. 58(6). 6 indexed citations
3.
Yang, Liu, Michael S. Hu, Yilan Shen, et al.. (2025). Protective effects of Notoginsenoside R2 on reducing lipid accumulation and mitochondrial dysfunction in diabetic nephropathy through regulation of c-Src. Chinese Medicine. 20(1). 10–10. 1 indexed citations
4.
An, Xiaoning, Min Yin, Yilan Shen, et al.. (2025). Dimethyl fumarate ameliorated pyroptosis in contrast-induced acute renal injury by regulating endoplasmic reticulum stress and JAK2-STAT3 pathway. Renal Failure. 47(1). 2504633–2504633. 6 indexed citations
5.
6.
Fang, Si, et al.. (2024). TET3 Contributes to Exercise‐Induced Functional Axon Regeneration and Visual Restoration. Advanced Biology. 9(6). e2400145–e2400145. 1 indexed citations
7.
Cao, Zhonglian, Hui Zhao, Jiajun Fan, et al.. (2023). Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. Cell Death Discovery. 9(1). 8–8. 16 indexed citations
8.
Shen, Yilan, Yuqing Xu, Pei Kang Shen, et al.. (2023). A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation. Applied Microbiology and Biotechnology. 107(7-8). 2561–2576. 4 indexed citations
9.
Wei, Miaomiao, Dong‐Sheng Cheng, Haiying Zhang, et al.. (2023). Notoginsenoside Fc ameliorates renal tubular injury and mitochondrial damage in acetaminophen-induced acute kidney injury partly by regulating SIRT3/SOD2 pathway. Frontiers in Medicine. 9. 1055252–1055252. 16 indexed citations
10.
Chen, Hongbo, Kai Yin, Yilan Shen, et al.. (2022). Formononetin Attenuates Renal Tubular Injury and Mitochondrial Damage in Diabetic Nephropathy Partly via Regulating Sirt1/PGC-1α Pathway. Frontiers in Pharmacology. 13. 901234–901234. 29 indexed citations
11.
Gu, Yuting, Yilan Shen, Wei Chen, et al.. (2022). Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response. Applied Microbiology and Biotechnology. 106(7). 2637–2649. 7 indexed citations
12.
Chen, Wei, Yilan Shen, Jiajun Fan, et al.. (2021). IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury. SHILAP Revista de lepidopterología. 11(2). e324–e324. 28 indexed citations
13.
Su, Jun, Ling Xie, Ying Fan, et al.. (2021). Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats. Frontiers in Pharmacology. 12. 638422–638422. 51 indexed citations
14.
Shen, Yilan, Xin Jin, Wei Chen, et al.. (2020). Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses. Applied Microbiology and Biotechnology. 104(13). 5889–5898. 27 indexed citations
15.
Shen, Yilan, Wei Chen, Lei Han, et al.. (2020). VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharmaceutica Sinica B. 11(1). 127–142. 44 indexed citations
16.
Chen, Wei, Wenjing Zai, Jiajun Fan, et al.. (2020). Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury. Theranostics. 10(13). 5879–5894. 24 indexed citations
17.
Shen, Yilan, et al.. (2020). Transgenic Tarantula Toxin: A novel tool to study mechanosensitive ion channels in Drosophila. Journal of Insect Physiology. 127. 104116–104116. 5 indexed citations
18.
Ding, Tao, Shaofei Wang, Xuyao Zhang, et al.. (2018). Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine. 41. 45–53. 160 indexed citations
19.
Tang, Jiqiang, Youguang Zhang, & Yilan Shen. (2012). Throughput Analysis of the Cooperative MAC for IEEE 802.11b Wireless LANs. INTERNATIONAL JOURNAL ON Advances in Information Sciences and Service Sciences. 4(1). 19–27.
20.
Handel, Stephen, et al.. (2010). The College Completion Agenda: State Policy Guide.. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zi-Yue Wan Breakdown of academic impact, for papers by Zeyuan Lin Breakdown of academic impact, for papers by Haiming Xiao Breakdown of academic impact, for papers by Zhimin Mao Breakdown of academic impact, for papers by Yuebo Huang Breakdown of academic impact, for papers by Bu-Hui Liu Breakdown of academic impact, for papers by Yongli Zhan Breakdown of academic impact, for papers by Yuan-ye Qiu Breakdown of academic impact, for papers by Pengxun Han Breakdown of academic impact, for papers by Anmei Shu
Rankless by CCL
2026